Table 3.
Model | Way of Generation | Advantages | Disadvantages |
---|---|---|---|
Ectopic CDX Cell line-Derived Xenograft |
Human tumor cells (fluorescents or not) Implanted subcutaneously | Easy, fast, and cheap Commercial cell lines or primary cell cultures Eeasily measurable |
Immunodeficient host Some cancer types fail to grow Not specific tissue growing |
Orthotopic CDX Cell line-Derived Xenograft |
Implantation on specific tissue | Microenvironment similar to the origin of the tumor Eeasily measurable |
They are more technically complex than ectopic Immunodeficient host Not all cancer types grow |
Metastatic CDX | By injection of tumor cells by vein or intra-cardiac | Tumors can grow in a variety of tissues or organs | The model does not mimic the original tumor Technically demanding to detect the location of tumor |
PDXPatient-Derived Xenografts | By implantation of tumor cells or fragment derived from human tumors. (ectopically or orthotopically) |
Tumors generated maintain the phenotypic and genotypic characteristics of the original tumor derived from the patient | Requires fresh patient tumor tissue Immunodeficient host Relatively expensive Slow implementation Technically demanding |
Syngeneic | Mouse tumor tissue or cells implanted on same strain mouse | Good growing tumors Microenvironment adequate Immunocompetent host |
Mouse microenvironment Not useful as human model |
Conventional GEMM Genetically Modified Mouse Models |
Oncogenic-driven transgenic mice to develop specific cancer. | Natural microenvironment Intact immune system Modelling of early/late stages of tumor progression |
Mouse microenvironment Not truly of human disease Not valuable for certain test therapies |